Skip to content

A randomised, double blind clinical trial comparison the effect of a ultrasound-guided transversus abdominis plane (TAP) block and wound infiltration on postoperative pain (48h) for open inguinal hernia repair in day-care

A randomised, double blind clinical trial comparison the effect of a ultrasound-guided transversus abdominis plane (TAP) block and wound infiltration on postoperative pain (48h) for open inguinal hernia repair in day-care - clinical trial comparing effect of TAP-block for open ing. hernia repair

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
NL-OMON
Registry ID
NL-OMON42102
Enrollment
60
Registered
2014-08-07
Start date
2014-11-24
Completion date
Unknown
Last updated
2024-06-11

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

post-operative pain after inguinal hernia repair

Interventions

Perioperative echo guided TAP block.

Sponsors

Westfries Gasthuis
Lead Sponsor

Eligibility

Age
18 Years to 99 Years

Inclusion criteria

Inclusion criteria: age between 18-80, competent, elective surgical treatment, Body Mass Index (BMI) between 20-35

Exclusion criteria

Exclusion criteria: fever, a coagulation disorder (based on case history and pre-operative assessment questionary) , patiënts with kidney and or liver faillure (based on case history and pre-operative assessment questionary), an infection at the place by the puncture place, preoperative use of narcotics, NSAID's or paracetamol

Design outcomes

Primary

MeasureTime frame
Primary objective is to analyse, differences in pain scores between the 2 groups until 48 hours after the operation.

Secondary

MeasureTime frame
Secondary objectives are; time to to first use of intravenous Morfine, the total amount of titrated postoperative Morfine, use of Tramadol at home, patient satisfaction en the incidence of nausea and vomiting.

Countries

Netherlands

Outcome results

None listed

Source: NL-OMON (via WHO ICTRP)